NUPR1 and familial pancreatic carcinoma: While investigating the pathways that lead to drug resistance, the transcriptional regulator NUPR1 (also known as anti-apoptotic protein p8 or Candidate of Metastasis-1) was identified as being involved in the acquisition of gemcitabine resistance by pancreatic cancer cells [39].